Discover Great Companies Discover Great Clients
Popularity  2.4万   |   Followers  6   |   Likes  8   |   Feedback  10 Claim this company

Antibody biopharmaceutical developer

Suzhou Industrial Park Jiangsu No.15 Kang Ti Yao No.16 Lin Chuang Qian Yan Jiu No.28 Fen Zi Sheng Wu Xue No.53 Antibodies No.68 Xin Yao R&D No.76 Innovative Drugs Biotechnology Pharmaceuticals Sheng Ming Ke Xue Biological Products Yao Products R&D Biopharmaceuticals Zhi Yao / Yao Industries 瞪羚企业 科技型中小企业 省科技型中小企业 市级创新型中小企业
More

Company Overview

  • Nature: Foreign Enterprise Representative Office Size: 100-499 employees Founded: 14年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Adagene (Suzhou) Co., Ltd.。

Development Stage

  • Stage: 战略投资, 2500万美元。
  • Honors: 瞪羚企业 科技型中小企业 According to algorithm
  • News: 2020-11-11:天演药业计划在美ipo,或筹资约2亿美元。

About the Company

[Summary] Antibody biopharmaceutical developer

Adagene (Suzhou) Co., Ltd. is a biopharmaceutical company dedicated to the development of original antibody technologies and its pipeline. Founded in February 2012, the company is located in BioBAY, Suzhou. It currently has 2,246 square meters of R&D space and 125 employees, whose members graduated from top international institutions such as the University of Chicago, Caltech, Yale University, Los Alamos National Laboratory, Université de Paris, ETH Zurich, Peking University, and the Chinese Academy of Sciences. Adagene perfectly combines information technology with biotechnology to develop its proprietary Dynamic Precision Antibody technology, and uses this technology to develop therapeutic and diagnostic mono- and bispecific antibody drugs against specific tumor targets, while focusing on the product development and collaboration of mono- and bispecific antibodies. In 2015, Adagene completed its Series B financing, successfully completed project collaborations with a number of well-known domestic and international pharmaceutical companies, and is committed to building its own innovative product pipeline.
Adagene has established a world-leading near-trillion-level developable antibody library and built a screening platform seamlessly integrating phage and yeast. It can precisely design, construct and screen therapeutic antibodies, and can generate monospecific and bispecific antibodies against different targets, and these antibodies have particularly excellent target cross-reactivity, enabling faster identification of in vivo and in vitro efficacy and safety of products and accelerating clinical development.
The company is currently developing rapidly and sincerely invites talented individuals with foresight, leadership, independent thinking, and the desire to make a career in a new innovative company combining information and biotechnology to join us. Adagene offers a broad development platform and generous compensation and benefits.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Adagene Financing History (8 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 2500万美元
  • Investor: 赛诺菲

Adagene honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,000万(元)
Legal Representative: PETER LUO
Date Established:
Credit Code: 91320594590011964Y
Registered Address: 中国(江苏)自由贸易试验区苏州片区苏州工业园区星湖街218号生物纳米科技园C14楼301室

Partners & Suppliers

药明合联为天演药业提供ADC药物的偶联工艺开发服务 Source
供应商 ADC药物合作研发

People who follow Adagene also follow

Adagene Competitors (Similar Companies)

医药 药物研发 医药工业 创新药
生物科技/生物工程 药物研发 医药 试剂

Discover Great Companies, Discover Great Clients

苏州公司名录 苏州“Industrial Park”公司名录 苏州“制药/药业”公司名录 苏州“抗体”公司名录 苏州“药物研发”公司名录 苏州“生物制药”公司名录 苏州“创新药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates